# Pharmacological effects and mechanisms of medicine food homology species and active ingredients in ameliorating ovarian aging

**Authors:** Jiayi Chen, Xiaotian Li, Xinle Lai, Ruoyi Xu, Zheqi Liu, Jia Xing, Liuqing Yang, Qin Zhang

PMC · DOI: 10.3389/fnut.2025.1756703 · Frontiers in Nutrition · 2026-01-21

## TL;DR

This review explores how certain food and medicinal ingredients may help delay ovarian aging through multiple biological mechanisms.

## Contribution

The paper highlights the novel potential of medicine food homology species and their active ingredients in ameliorating ovarian aging via multi-pathway effects.

## Key findings

- MFH species and active ingredients show antioxidant, anti-inflammatory, and apoptosis inhibitory effects.
- They influence signaling pathways like PI3K/Akt and Nrf2/HO-1 to maintain ovarian function.
- MFH species offer multi-target therapeutic potential for developing health foods and functional preparations.

## Abstract

Ovarian aging is the process of decline in ovarian reserve, endocrine function with age, leading to reduced fertility and increased risk of various related diseases. In recent years, medicine food homology (MFH) species have attracted much attention for their potential to delay ovarian aging due to their dietary and medicinal values. In this review, we have focused on the intervention of MFH species and active ingredients on ovarian aging, with an emphasis on the molecular mechanisms involved in antioxidant, anti-inflammatory, apoptosis inhibitory, balance of autophagy, maintenance of genome stability, mitochondrial function protective and estrogen-like effects through multiple signaling pathways (e.g., PI3K/Akt, Nrf2/HO-1, SIRT1/mTOR, Nrf2/ARE, etc.). Possessing the characteristics of multi-pathway and multi-target effects, MFH species and active ingredients provide new ideas for the research and development of health food and functional preparations. High-quality clinical studies are still needed for verification.

## Full-text entities

- **Genes:** MTOR (mechanistic target of rapamycin kinase) [NCBI Gene 2475] {aka FRAP, FRAP1, FRAP2, RAFT1, RAPT1, SKS}, SIRT1 (sirtuin 1) [NCBI Gene 23411] {aka SIR2, SIR2L1, SIR2alpha}, HMOX1 (heme oxygenase 1) [NCBI Gene 3162] {aka HMOX1D, HO-1, HSP32, bK286B10}, AKT1 (AKT serine/threonine kinase 1) [NCBI Gene 207] {aka AKT, PKB, PKB-ALPHA, PRKBA, RAC, RAC-ALPHA}, NFE2L2 (NFE2 like bZIP transcription factor 2) [NCBI Gene 4780] {aka IMDDHH, NRF2, Nrf-2}, PIK3CB (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta) [NCBI Gene 5291] {aka P110BETA, PI3K, PI3KBETA, PIK3C1}
- **Diseases:** inflammatory (MESH:D007249)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12867837/full.md

## Figures

5 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12867837/full.md

## References

232 references — full list in the complete paper: https://tomesphere.com/paper/PMC12867837/full.md

---
Source: https://tomesphere.com/paper/PMC12867837